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1991-7902/Copyrightª 2014, AssociatioAbstract Background/purpose: b-Tricalcium phosphate (b-TCP) is an osteoconductive mate-
rial. Earlier reports revealed that silica plays an important role in bone mineralization, and its
incorporation would enhance the biocompatibility of implants.
Materials and methods: In this study, silica doping at various concentrations (0 wt.%, 10 wt.%,
20 wt.%, and 30 wt.%) was performed. Si-aˆ-TCP was obtained upon calcining the as-prepared
powders at 1400C. To check its effectiveness, different Si-aˆ-TCP samples were prepared to
make new bioactive and biodegradable biocomposites for bone repair. Formation of bonelike
apatite, the diametral tensile strength, ions released, and weight loss of composites were
considered before and after immersion in simulated body fluid. We also examined the behavior
of human dental pulp cells (hDPCs) cultured on these materials.
Results: The results showed that the apatite deposition ability of the b-TCP was enhanced as
the Si content was increased. For composites with >20% Si content, the apatite layer covered
the samples. At the end of the immersion point, weight losses of 52%, 45%, 33%, and 26% were
observed for the b-TCP containing 0%, 10%, 20%, and 30% Si, respectively. In vitro cell exper-
iments showed that the Si-rich cement promotes hDPC proliferation and differentiation. How-
ever, when the Si content in the cement is >20%, the amount of cells and osteogenesis protein
of hDPCs were stimulated by Si released from Si-b-TCP.
Conclusion: The degradation of b-TCP and osteogenesis of Si give us a strong reason to believe
that these Si-based cements may prove to be promising bone repair materials.entistry, Chung Shan Medical University, Taichung City, Taiwan.
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The suitable bioactivity and appropriate degradation of
materials are required to conform to different clinical re-
quirements for hard tissue repair. Autograft possesses all
the characteristics indispensable for new bone formation,
osteogenesis, osteoconductivity, and osteoinductivity, and
it is currently considered the gold standard in this field. In
spite of its strengths, however, there are still various dis-
advantages when using this material for certain medical
clinical applications. This approach regrettably minimizes
reconstructive healing and, even worse, sometimes pro-
motes foreign body reaction. Therefore, efforts are ongoing
to design better biomaterials that allow good control of
material physicochemical properties.
Silicate (Si)-based cements have received a considerable
amount of positive attention in recent years because these
materials have a better bioactivity than calcium phosphate-
based materials.1,2 Recently, several studies have indicated
that Si-based materials can play an important role in bone
formation, at least based on these materials’ Si ion release3
and fast apatite formation ability.4,5 Si-based materials can
promote human mesenchymal stem cells, human dental
pulp cells (hDPCs), and osteoblast-like cell adhesion, pro-
liferation, and differentiation.6e11 Furthermore, the Si-
based cement was able to activate angiogenesis12 and
antiosteoclastogenesis.13 These studies demonstrate that
Si-based cement has the ability to promote the apatite
layer to form in vitro14 and also shows it is better at pro-
moting bone regeneration in vivo.15 However, the slow
degradation rate of Si-based materials may result in a
decrease in osteoconductivity, which may restrict their
application in clinical practice.16 In order to ameliorate its
relative disadvantage in regard to material degradation, we
used b-tricalcium phosphate (b-TCP) as an additive to see
how this would affect its rate of decay. b-TCP is a bio-
ceramic material that is widely used for hard tissue repair.
It has a chemical composition similar to apatite present in
bone tissue, and has been applied extensively as a bone
grafting material.17,18 Previous studies have shown that
wollastonite-doped TCP bioceramic has a higher degrada-
tion rate and promotes new bone formation better than
TCP in vivo.15 Wang et al19 assert that the composite
scaffolds containing50% and 80% calcium silicate not only
have good osteoconductivity, but also promote rapid bone
formation compared with pure b-TCP and calcium silicate
scaffolds.
Thus, to obtain both osteostimulation and osteo-
conductivity by taking advantage of the favorable bioac-
tivity of silica and the high degradability of b-TCP, Si-doped
b-TCP cements have been produced in the hopes that the
right mixture can help to control the degradation rate and
improve interactions of the material with human tissue.
In this study, Si-doped b-TCP cements with varying ratios
were prepared so that we could observe the changes inphysiochemical properties, bioactivity, in vitro degradation
behavior, osteogenesis, and antibacterial activity with
different ratios of Si doped. It is our hope that this knowl-
edge may help in the design of optimal biomaterials for
bone regeneration.
Materials and methods
Preparation of Si-doped b-TCP cement
The reagent grade SiO2 (Sigma-Aldrich, St. Louis, MO, USA)
and b-TCP (Sigma-Aldrich) powders were used as matrix
materials. The SiO2 and b-TCP mixtures were sintered at
1400C for 3 hours using a high-temperature furnace, and
then ball-milled in ethyl alcohol using a centrifugal ball mill
(S 100; Retsch, Hann, Germany) for 6 hours. The specimen
codes “Si10”, “Si20” and “Si30” were used to indicate
cement containing 10 SiO2/90 b-TCP, 20 SiO2/80 b-TCP, and
30 SiO2/70 b-TCP (in wt.%), respectively. Si0 is the b-TCP
group. The powder was mixed using a liquid/powder ratio
of 0.25 mL/g. After mixing with liquids (1M Na2HPO4), the
cements were molded in a Teflod mold (diameter, 6 mm;
height, 3 mm). The cement quantities were such they fully
covered each well of the 24-well plate (GeneDireX, Las
Vegas, NV, USA) to a thickness of 2 mm for cell experi-
ments. All samples were stored in an incubator at 100%
relative humidity and 37C for 1 day of hydration.
Setting time and strength
After the powder was mixed with liquid, the cement was
placed into a cylindrical mold and stored in an incubator at
37C and 100% relative humidity for hydration. The setting
time of the cements was tested according to the standards
set by the International Standards Organization 9917-1. The
setting time was recorded when the Gilmore needle failed
to create a 1-mm-deep indentation in three separate areas.
After being taken out of the mold, the composite spec-
imens were incubated at 37C in 100% humidity for 1 day.
Diametral tensile strength (DTS) testing was conducted on
an EZ-Test machine (Shimadzu, Kyoto, Japan) at a loading
rate of 1 mm/minute. The maximal compression load at
failure was obtained from the recorded loadedeflection
curves. At least 10 specimens from each group were tested.
In vitro soaking
To evaluate the in vitro bioactivity, the cements were
immersed in a 10-mL simulated body fluid (SBF) solution at
37C. The solution in the shaker water bath was not changed
daily under a static condition. After soaking for different
time durations (from 3 days to 3 months), specimens were
removed from the tube and evaluated for several physico-
chemical properties.
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The morphology of the cement specimens before and after
immersion in SBF were coated with gold and examined
under a scanning electron microscope (JSM-6700F, JEOL,
Tokyo, Japan) operated in the lower secondary electron
image mode at 3 kV accelerating voltage.
Weight loss
The degree of degradation was determined by monitoring
the weight change of the specimens. After drying at 60C,
the composites were weighed both before and after im-
mersion using a balance. Ten repeated specimens were
examined for each of the materials investigated at each
time point.
Ion concentration
The concentration of Ca, Si, and P ions released from
cement on SBF was analyzed using an inductively coupled
plasma atomic emission spectrometer (Perkin-Elmer OPT
1 MA 3000DV; Perkin-Elmer, Shelton, CT, USA) after im-
mersion. Three samples were measured for each data
point. The results were obtained in triplicate from three
separate samples for each test.
Dental pulp cell isolation and culture
The hDPCs were freshly derived from caries-free, intact
premolars that were extracted for orthodontic treatment
purposes, as described previously.12 A sagittal split was per-
formed on each tooth using a chisel, and the pulp tissue was
immersed in a phosphate buffered saline (PBS) solution. Pulp
tissue was then cut into fragments, distributed into plates,
and cultured in Dulbecco’s modified Eagle’s medium (DMEM),
supplemented with 20% fetal bovine serum (Caisson, North
Logan, UT), 1% penicillin (10,000 U/mL)/streptomycin
(10,000 mg/mL) (Caisson), and kept in a humidified atmo-
sphere with 5% CO2 at 37
C; themediumwas changed every 3
days. The osteogenic differentiation medium was DMEM
supplemented with 108M dexamethasone (Sigma-Aldrich),
0.05 g/L L-ascorbic acid (Sigma-Aldrich), and 2.16 g/L glyc-
erol 2-phosphate disodium salt hydrate (Sigma-Aldrich).
Cell viability
Cell suspensions at a density of 104 cells/mL were directly
seeded over each specimen for different days. Cell cultures
were incubated at 37C in a 5% CO2 atmosphere. After
different culturing times, cell viability was evaluated using
the PrestoBlue (Invitrogen, Grand Island, NY, USA) assay.
Briefly, at the end of the culture period, the medium was
discarded and the wells were washed with cold PBS twice.
Each well was then filled with the medium with a 1:9 ratio of
PrestoBlue in fresh DMEM and incubated at 37C for 30 mi-
nutes, after which the solution in each well was transferred
to a new 96-well plate. Plates were read in a multiwell
spectrophotometer (Hitachi, Tokyo, Japan) at 570 nmwith a
reference wavelength of 600 nm. Cells cultured on thetissue culture plate without the cement were used as a
control (Ctl). The results were obtained in triplicate from
three separate experiments in terms of optical density (OD).
Osteogenesis assay
The level of alkaline phosphatase (ALP) activity was
determined after cell seeding for 3 days and 7 days. The
process was as follows: the cells were lysed from disks using
0.2% NP-40, and centrifuged for 10 minutes at 2000  g
after washing with PBS. ALP activity was determined using
p-nitrophenyl phosphate (Sigma-Aldrich) as the substrate.
Each sample was mixed with p-nitrophenyl phosphate in 1M
diethanolamine buffer for 15 minutes, after which the re-
action was stopped by the addition of 5N NaOH and quan-
tified by absorbance at 405 nm. All experiments were done
in triplicate.
The osteocalcin (OC) protein released from pulp cells
were cultured on different substrates for 7 days and 14 days
after cell seeding. An OC enzyme-linked immunosorbent
assay kit (Invitrogen) was used to determine OC protein
content following the manufacturer’s instruction. The OC
protein concentration was measured by correlation with a
standard curve. The analyzed blank disks were treated as
controls. All experiments were performed in triplicate.
Alizarin Red S stain
Accumulated calcium deposition was observed for 14 days
using Alizarin Red S staining as described in a previous
study.20 To summarize briefly, the cells were fixed with 4%
paraformaldehyde (Sigma-Aldrich) and then incubated in
0.5% Alizarin Red S (Sigma-Aldrich) at pH 4.2 for 15 minutes
at room temperature in an orbital shaker (25  g). To
quantify the stained calcified nodules after staining, sam-
ples were immersed with 1.5 mL of 5% sodium dodecyl
sulfate (SDS) in 0.5N HCl for 30 minutes at room tempera-
ture, following which the tubes were centrifuged at
5000  g for 10 minutes and the supernatant was trans-
ferred to the new 96-well plate (GeneDireX). At this time,
absorbance was measured at 405 nm (Hitachi).
Antibacterial property
To investigate the antibacterial effect of Si-doped b-TCP
cement, the hydration composites were mixed with 1 mL
Staphylococcus aureus in LB culture medium (4.0  104
bacteria/mL) and cultured for 3 hours and 12 hours. Ali-
quots of 0.1 mL from each group were mixed with 0.9 mL
PrestoBlue for 30 minutes. The solution in each well was
transferred to a new 96-well plate. Plates were read in a
multiwell spectrophotometer (Hitachi) at 570 nm with a
reference wavelength of 600 nm. Cells cultured on the
tissue culture plate without the cement were used as a Ctl.
The results were obtained in triplicate from three separate
experiments in terms of OD.
Statistical analysis
A one-way analysis of variance statistical analysis was used
to evaluate the significance of the differences between the
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test was used to determine the significance of the de-
viations in the data for each specimen. In all cases, the
results were considered statistically significant if P < 0.05.
Results
Setting time and strength
After mixing with liquid, the working time of Si0, Si10, Si20,
and Si30 was 11 minutes, 11 minutes, 8 minutes, and 7
minutes, respectively (Fig. 1A). As the amount of Si doped
increased, the setting time of the cement becomes shorter,
going from 70 minutes (Si0 group) all the way down to 31
minutes (Si30 group), which represents a significant dif-
ference (P < 0.05). The DTS values of hydration cements
ranged from 1.4 MPa to 2.6 MPa, indicating a significantFigure 1 (A) The working, setting time and (B) diametral
tensile strength of various Si-doped b-tricalcium phosphate
hydrate. Statistical data are presented as mean  standard
deviation (nZ 6). * Significant difference (P < 0.05) compared
to Si0.(P < 0.05) increase in the strength as the amount of Si
amount is increased (Fig. 1B).
Morphology of immersed cements
The results of an examination of the surface microstructure
of the specimens before and after immersion in SBF after 3
days and 7 days are shown in Fig. 2. It is readily visible that
the Si0 cement has a looser and rougher surface texture,
with irregular pores. By contrast, the Si30 cement exhibits a
dense and smooth surface containing particle entangle-
ment and micropores. The formation of the bonelike
apatite in SBF has proven to be useful in predicting the
bone-bonding ability of material in vitro. It can be seen
that the apatite layer covers the surfaces of Si20 and Si30
content after immersion for 7 days. However, it is clear that
no precipitate has formed on the surfaces of Si0 and Si10.
Weight loss
Dissolubility is one of the important factors in biodegrada-
tion21 that must be considered when trying to develop a
material with a degradation rate most appropriate for
hastening and easing the process of bone repair. With this in
mind, the degradation rates of the Si-doped b-TCP in SBF
solution have been recorded for various time intervals
ranging from 3 days to 12 weeks, as shown in Fig. 3. After
soaking for 1 week, the Si30 cement shows a relatively
modest amount of weight loss (w18.2%), whereas the Si0
cement lost considerably more weight (w26.3%). All sam-
ples showed an increased weight loss as the immersion time
is increased. The Si30 cement has the lowest dissolution
rate and solubility compared with other samples over the
whole immersion period, reaching 26.0% after 12 weeks. By
contrast, the overall amount of Si0 dissolution reached
52.4% after 12 weeks. At the end of the soaking point,
weight losses of approximately 45.3%and 33.4% were
observed for Si10 and Si20 cements, respectively, indicating
significant differences (P < 0.05).
Ion concentration
Variations of Ca, Si, and P ion concentrations in SBF after
different soaking periods are shown in Fig. 4. After im-
mersion for 1 day, Ca ion concentration in the Si30 group
was decreased to approximately 1.76 mM, which was lower
than that in the Si0group (1.92 mM, P < 0.05). As for P ion
concentration of SBF, the Si30 group also decreased after 1
day of immersion. Si concentrations increased with
increasing incubation time points. Si ion concentration was
in the range of 1.2 mM, 1.5 mM, and 1.9 mM at Si10, Si20,
and Si30 for 1 week, respectively.
hDPC proliferation
Cell behavior and functions associated with the bone
cement is closely related to the physicochemical and bio-
logical properties of the materials used. To consider the
effects of Si doped on osteogenic activity, the biological
functions of hDPCs cultured on various cement specimens
were evaluated for different time points (Fig. 5). The cell
Figure 2 Scanning electron micrographs of Si-doped b-tricalcium phosphate cement surfaces before and after immersion in
simulated body fluid for 3 days and 7 days.
Figure 3 Weight loss of various cements after immersion in
simulated body fluid for predetermined time durations.
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amount of Si doped into b-TCP, indicating a significant
difference (P < 0.05) compared with the Si0 cement. For
example, on Day 1 the Si30 cement showed an increase of
approximately 32% in the OD value in reference to the Si0
cement. The Si0 cement elicited a significant decrease of
25%, 27%, and 20% in comparison with the Si30 cement on
Day 1, Day 3, and Day 7 of cell culture, respectively.
Osteogenesis protein secretion
Osteogenesis differentiation of cells is one of the key steps
to determine the level of success in bone formation. The
ALP secretion of hDPCs cultured on different cements has
also been examined. Fig. 6A shows the analysis of quanti-
tative examination data and the ALP activity of cells
cultured on the different composites for 3 days and 7 days.
The ALP level increased with increasing of Si content in the
cements at all incubation times. A significant 32% and 54%
increase (P < 0.05) in the ALP level was measured for Si20
and Si30 in comparison with the Si0 cement for 7 days.
Similarly, the OC secretion by cells cultured on the Si30
cement is significantly higher (P < 0.05) than that secreted
Figure 4 (A) Ca, (B) Si, and (C) P ions concentration of
simulated body fluid after immersion for different times. Data
are presented as mean  standard deviation (n Z 6). * Sta-
tistically significant difference compared to Si0.
Figure 5 Proliferation of human dental pulp cells treated
with various specimens for 7 days. * Significant difference
(P < 0.05) compared to Si0.
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37% and 22% in cells cultured on Si30 and Si20 in comparison
with the Si0 cement for 14 days.
Mineralization
Bone nodule was clearly seen in cells in the presence of
Si20 and Si30 after culture for 1 week, whereas calciumdeposition in the Si0 cement was only lightly stained (Fig. 7).
ByWeek2,amore intensecalciumstainingwasexhibited.The
corresponding quantification of calciummineral deposition is
also shown in Fig. 7B. In the case of the Si-doped cement,
significant (1.19-, 1.89-, and 2.13-fold) enhancement
(P< 0.05) of calcium content was observed on Si10, Si20, and
Si30 compared with Si0 cement on Week 2, respectively.
Antibacterial property
Besides the osteostimulation property of the cements,
these bone grafts demonstrated that they also had a sig-
nificant antibacterial effect (Fig. 8). The S. aureus cultures
with Ctl and Si0 showed the highest absorbance at the
different times observed (P < 0.05). However, the anti-
bacterial activity of Si-doped b-TCP cement was promoted
when the Si content was increased. For example, at 24
hours the Si30, Si20, and Si10 cements exhibited a decrease
of approximately 46%, 30%, and 9%, respectively, in the OD
value referenced to the Si0 cement.
Discussion
Calcium phosphate-based cements consist of a powder
containing one or several solid compounds of calcium
phosphate salts and a liquid phase that can be water or the
solution.22 Calcium phosphate cements, especially b-TCP,
have a wide application in reconstructive bone surgery. In
physiological content, b-TCP quickly degrades by both
chemical dissolution and osteoclastic resorption, and af-
fects the bone-remodeling process.23 Thus, this study shows
several beneficial effects derived from the simultaneous
presence of SiO2 dopants in b-TCP. Furthermore, the effect
of SiO2 dopants in b-TCP on hDPC behavior and its activity is
demonstrated.
The setting time is one of the key factors in clinical
requirements. A long setting time could cause problems
clinically because of the cement’s inability to maintain
Figure 6 (A) Alkaline phosphatase activity and (B) osteo-
calcin (OC) amount of human dental pulp cells cultured on
various specimens for different times. * Significant difference
(P < 0.05) compared to Si0.
288 S.-H. Huang et alshape and support stresses within this period.24 In this
study, when 1M Na2HPO4 was used as a liquid phase, the
setting time of the control cement was 70 minutes,
consistent with previously reported results.20 In the present
study, the setting time of silicate-based cements was pro-
portional to the calcium silicate hydrate amount.25 Calcium
silicate hydrate is able to reduce the setting time of the
calcium-based cement. Moreover, our results show that a
setting time of approximately 30 minutes for injectable
bone cements for use in vertebroplasty and kyphoplasty26 is
possible. In the bone cement, it is believed that when
bonded to natural bone, the apatite layer will precipitate
on the surface.14 The formation of the bonelike apatite in
SBF has proven to be useful in predicting the bone-bonding
ability of materials in vitro. It can be seen that the apatite
layer covers the surfaces of specimens with Si20 and Si30after immersion. After immersion, the surface of the two
samples is completely covered by an apatite layer with tiny
ball-like shapes on the surface. However, it is clear that no
precipitate has formed on the surfaces of the b-TCP-rich
cement (Si0 and Si10). These results are similar to reports
by other researchers,15,27 who elucidate the lack of apatite
formation observed in b-TCP samples after soaking in SBF
for several days.20 The in vitro bioactivity of the silicate-
based materials indicates that the presence of PO4
3 ions
in the composition is not an essential requirement for the
formation of the apatite layer, which is noteworthy
because it is known that PO4
3 depletes calcium and phos-
phate ions because the PO4
3 ions originate from the in vitro
assay solution.25 Most importantly, the SieOH functional
group on Si-based has been proven to act as the nucleation
center for apatite formation.4 This may explain why the
b-TCP cement had no bioactivity. Thus, the Si-doped b-TCP
cements were supposed to develop a stronger bond with
the surrounding bone tissue compared with the b-TCP-rich
cement. As expected, Si-doped b-TCP cements showed an
intermediate dissolution behavior similar to that exhibited
by pure b-TCP. Moreover, as the Si content is increased, the
dissolution rate also decreases steadily. Hence, the degra-
dation rate of the cements may be controlled to a certain
extent by varying the Si content in the cement.27 Taking
cell functions into account, the appropriate Si released
from silicate-based materials may support cell behav-
iors.28e31 Currently available Si-based materials offer users
the ability to control the rate of soluble Si ion, which in turn
affects cell adhesion and proliferation.25,32
Regarding biocompatibility, it is certainly evident that no
bone grafts showed signs of cytotoxicity. Cell behavior
associated with bone cement is closely related to the bio-
logical properties of the materials used. To elucidate the
effects of Si doping on proliferation and osteogenic activity
of pulp, cells cultured on various specimens were evalu-
ated. Cell proliferation was higher when there was a higher
Si content in the cement. Si content was likely to be the key
factor in cell attachment and proliferation as there was a
reciprocal relationship in Ca concentration.3,9,25 There is a
genetic control of the cellular response of osteoblasts to
the bone cements. Osteoblast differentiation is generally
accompanied by ALP and OC secretion. The secretion of ALP
from hDPCs was initiated earlier during culture on the higher
Si-doped cement surface (Si30) than on the lower Si content
cement (Si0), consistent with ALP amounts on the culture
medium. It is generally accepted that an increase in the
specific activity of ALP in bone cells reflects a shift to a more
differentiated state. OC is a late marker of osteogenesis and
is the noncollagenous bone-matrix protein characteristic of
osteoblast synthetic function. Recent studies also show that
Si-based materials promote hDPC proliferation and differ-
entiation.3,9,25 This stimulatory effect may be attributed to
the dissolution of Si ions.3,4,33 According to the study, TCP
cement always fails to form a chemical bonding with hard
tissue at the early stage of the therapy because of its poor
bioactivity.27 Taken together, our data indicated that the
Si-doped cement might possess a higher potency to interact
with hDPCs and to enhance osteogenesis and calcium matrix
deposition compared with the pure b-TCP cement. Such a
system could combine the benefits of bone substrate prop-
erties, such as resorbability and osteoconductivity. Besides
Figure 7 (A) Alizarin red S staining and (B) quantification of calcium mineral deposits by human dental pulp cells cultured on
various cements for 1 week and 2 weeks. * Significant difference (P < 0.05) compared to Si0.
Figure 8 The antibacterial effect of Si-doped b-tricalcium
phosphate cement for 3 hours, 12 hours, and 24 hours. * Sig-
nificant difference (P < 0.05) compared to Si0.
Properties of silica-doped b-tricalcium phosphate 289the osteostimulation property of the bone cement, Si-doped
b-TCP is also shown to have a significant antibacterial ef-
fect. There may be two potential reasons for the antibac-
terial effect of Si-based cement. One is that Si-based
material can release Ca and Si ions, leading to a weak
alkaline microenvironment with higher pH value, which may
restrain bacterial growth15,34; the other is that the calcium
silicate particles themselves could permeate into the bac-
teria,16,35 which could possibly promote the antibacterial
effect. Therefore, Si-doped b-TCP cement could be a
promising excellent antibacterial agent.
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